Rocket Lab Corporation ($RKLB) Stock Hub 2026: Record Q2, the Iridium S-4, Financing, Neutron and the Backlog Math
Rocket Lab now combines a record operating quarter with the most consequential financing decision in its history. The preliminary Iridium S-4 puts numbers around the acquisition, the pro forma balance sheet and the potential stock leg; the August 13 equity programme shows how management may reduce the bridge. The operating business is compounding fast and still loses money, while Neutron remains the industrial hinge of the thesis.
Get every Merlintrader report in real time on Telegram: join @merlintraderpub_com.
At a glance
Role split: SpaceX physically launched the satellites aboard Falcon 9; Globalstar is the customer, owner and constellation operator; MDA Space is the prime contractor and led payload development, final integration and testing; Rocket Lab supplied the 500-kilogram, Lightning-based spacecraft buses under its $143 million agreement with MDA. Rocket Lab reported contact with all eight platforms, nominal performance and on-orbit power generation. Globalstar reported that all eight HIBLEO-4 replacement satellites reached their intended orbital planes and were under control, with commissioning and testing now under way before operational service. This validates Rocket Lab’s Space Systems manufacturing and on-orbit operations execution; it was not an Electron or Rocket Lab launch-services mission. The remaining nine satellites in the 17-unit replenishment program are in final integration at MDA’s Montréal facility. This initial program is separate from MDA’s later contract to build more than 50 MDA AURORA satellites for Globalstar’s next-generation constellation.
The filing supplies the first combined pro forma financials and a preliminary purchase-price allocation. The HSR waiting period expired at 11:59 p.m. ET on August 12, while Rocket Lab and Iridium filed their FCC transfer applications on August 10. The S-4 is not yet effective, the Iridium meeting and record dates remain blank, and the acquisition still requires the shareholder vote and regulatory approvals. Official Form 425 update.
The new equity distribution agreement carries forward the unsold balance of the May 2026 $3.0 billion programme; it is not an additional $1.944 billion on top of that programme. Rocket Lab had already sold $1.0556 billion gross. The new structure permits ordinary ATM sales, initially priced forwards and collared forwards. Management is also seeking lender consent to leave Iridium’s approximately $1.775 billion term facility outstanding after closing. The final mix of cash, retained Iridium debt, permanent debt and equity remains unknown.
01 Executive Summary
This Rocket Lab stock hub tracks a company that has spent five years describing itself as an end-to-end space business, one that launches its own rockets and builds its own spacecraft. On June 28, 2026 it signed an agreement that, if it closes, adds the two pieces it could not build: an operating satellite constellation and the internationally coordinated spectrum to run it. It agreed to acquire Iridium Communications for $27.00 in cash plus a collared amount of stock for each Iridium share, a notional $54.00 that implies an enterprise value of approximately $8.0 billion.
The operating business underneath that announcement is growing quickly and still losing money. Second quarter 2026 revenue reached a record $234.07 million, up 62.0% year over year. GAAP gross margin was 36.1%, non-GAAP gross margin was 41.5%, and the adjusted EBITDA loss narrowed to $8.83 million from $27.58 million a year earlier. Backlog reached $2.36 billion, up 137% year over year, while cash and marketable securities rose to $2.39 billion after $1.53 billion of first-half ATM issuance. Total borrowings were only $14.8 million before any acquisition financing.
The share price tells a third story. $RKLB closed at $150.23 on May 27, 2026, rose 15.9% on the Iridium announcement day to $98.01 on June 29, fell to $58.60 on July 29 and rebounded to $82.83 on August 7. After a brief post-earnings pre-market drop, it closed at $80.01 on August 11 and at $80.25 on August 14. That is 46.6% below the May peak, 3.1% below the August 7 close and 15.0% above the December 31, 2025 close. The round trip occurred while the company signed its largest launch contract, won the $397 million SB-AMTI award, agreed to buy Iridium and completed its 92nd Electron mission.
Second quarter results were released after the close on Monday, August 10, 2026 and beat the guidance on every line management had set: revenue $234.1 million against the guided $225 million to $240 million, GAAP gross margin 36.1% against a guided 33% to 35%, non-GAAP gross margin 41.5% against a guided 38% to 40%, and an adjusted EBITDA loss of $8.8 million against a guided loss of $20 million to $26 million. GAAP net loss was $49.3 million, or $(0.08) per share. Backlog reached a record $2.36 billion, up 137% year over year, and management guided Q3 2026 revenue to $250 million to $265 million with an adjusted EBITDA loss of $17 million to $23 million. A margin print inside that band is guidance met rather than deterioration: segment mix explains most of the step down from 38.2%.
Three categories deserve to be kept apart when reading anything about this company. What is contracted and funded. What is signed but not closed. And what is a ceiling to compete against rather than an order. The third category is the one most often priced as though it belonged in the first.
Merlintrader framing: the verified operating file is unusually strong for a company at this stage: record revenue, a $2.36 billion backlog, $2.39 billion of liquidity and almost no pre-deal debt. The transaction file is now measurable rather than blank: the preliminary S-4 shows an illustrative 41.26 million-share stock leg, $7.59 billion of preliminary total consideration including debt payoff, and a pro forma balance sheet that assumes the full bridge. It is still not resolved. The S-4 is preliminary, permanent financing is not fixed, FCC and other approvals remain outstanding, the Iridium vote has not been scheduled, and Neutron has not flown.
02 Two Segments, And The One That Changed The Most
Rocket Lab reports two segments. Launch Services covers dedicated and rideshare launch. Space Systems covers spacecraft manufacturing and components. Space Systems has been the larger of the two for years, which is why the shorthand that Rocket Lab is a rocket company is out of date. What changed in the first quarter of 2026 was not the mix but the profitability of the smaller segment.
Quarter ended March 31, 2026. Percentages are each segment's share of the $200.348M consolidated total.
- Space SystemsGross profit $48.270M, margin 35.3%$136.685M68.2%
- Launch ServicesGross profit $28.223M, margin 44.3%$63.663M31.8%
Segment gross margins are calculated from the reported figures. A year earlier the same split was Space Systems $86.977M and Launch Services $35.592M, so the mix barely moved while the smaller segment's margin more than doubled.
Source: Rocket Lab Form 10-Q for the quarter ended March 31, 2026, segment note.
Launch Services gross margin rose from 20.3% to 44.3% in twelve months. That is the operating-leverage argument for a launch business stated in a single number: the fixed cost of three launch complexes, a factory and a workforce spread across roughly twice as many missions. It also explains why a guided margin step down for the second quarter is not automatically bad news, because a heavier Space Systems quarter dilutes the consolidated figure even when both segments perform.
Space Systems is now considerably broader than spacecraft assembly. It covers solar cells and panels, separation systems, star trackers and reaction wheels, radios, composite structures, space software, the Gauss electric thruster, laser optical terminals acquired with Mynaric and robotics acquired with Motiv. One concentration figure from the same filing belongs on the watch list: Kratos SRE, Inc. accounted for 21% of accounts receivable at March 31, 2026.
The distinction that makes the headlines readable: a launch contract adds revenue to Launch Services and is recognised as missions fly. A build-and-operate contract adds revenue to Space Systems and is recognised against manufacturing and service milestones. The $397 million Space Force award announced on August 4, 2026 is the second kind, which is why it is larger than the $266 million launch contract of July 27 without displacing it. Both descriptions can be true at once, and the segment they land in changes when the cash arrives.
03 The Iridium Acquisition: What Was Actually Signed
The transaction is documented in a Form 8-K filed on June 29, 2026 with the merger agreement attached, alongside a set of Rule 425 communications. Rule 425 covers written communications about a business combination, which is why several documents reached EDGAR the same morning: the joint press release, the investor presentation and the video material. The stream continued with employee communications and then became substantially more concrete on August 13, when Rocket Lab filed the preliminary Form S-4/proxy statement-prospectus, the related pro forma information and a financing update.
Structure and consideration
Rocket Lab entered into an Agreement and Plan of Merger with Iridium Communications Inc. and two wholly owned subsidiaries, Ion Merger Sub I, Inc. and Ion Merger Sub II, LLC. Merger Sub I merges into Iridium, and that entity then merges into Merger Sub II. The two-step structure is for tax reasons: the transaction is intended to qualify as a tax-free reorganisation, but only if the stock consideration relative to the cash consideration meets the required conditions at closing.
Each Iridium share converts into the right to receive $27.00 in cash plus Rocket Lab shares set by an exchange ratio that is not fixed. The ratio is defined against a Rocket Lab reference price, itself the volume-weighted average price over the ten consecutive trading days ending on the second full trading day before the merger becomes effective.
| Rocket Lab reference price | Exchange ratio | Value of the stock component | Total per Iridium share |
|---|---|---|---|
| At or below $67.50 | Fixed at 0.4000 | Below $27.00 | Below $54.00, falling with the share price |
| Above $67.50 and below $112.50 | $27.00 divided by the reference price | Exactly $27.00 | $54.00 |
| At or above $112.50 | Fixed at 0.2400 | Above $27.00 | Above $54.00, rising with the share price |
At the August 14, 2026 close of $80.25, Rocket Lab remained inside the collar, 18.9% above the $67.50 floor; a simple spot-price illustration gives an exchange ratio of approximately 0.3364 and about 35.65 million shares for the 105,956,272 Iridium shares used in the S-4. The filing itself uses the contractually relevant ten-day VWAP concept: a $69.3305 reference through August 7 produced an illustrative 0.3894 ratio and 41,259,372 Rocket Lab shares. Neither figure is the final closing ratio. Below $67.50 the ratio locks at 0.4000, so Iridium holders absorb further Rocket Lab price weakness directly.
What is being bought, in Iridium’s own numbers
Iridium is not a development-stage asset. It operates 66 satellites in low Earth orbit with 14 on-orbit spares, holds globally coordinated L-band spectrum rights, and sells voice, data, Internet of Things and positioning, navigation and timing services through more than 500 partner companies. In 2025 it reported revenue of $871.7 million and operational EBITDA of $495 million, a 57% margin on its own definition. Its latest filing shows continued growth: second quarter 2026 revenue of $225.24 million against $216.91 million a year earlier, approximately 2,627,000 billable subscribers at June 30, 2026, up 6% year over year, and first-half operating cash flow of $185.76 million.
The scale comparison is easy to miss. Rocket Lab’s trailing twelve-month revenue through June 30, 2026 was $769.15 million, still below Iridium’s $871.7 million in 2025. The gap has narrowed, but Rocket Lab is acquiring a company larger than itself on those dated revenue bases and profitable at the operational EBITDA line while Rocket Lab is not.
Financing the cash component
All four figures in US$ millions, on the dates stated. Bars are scaled to the $3.60 billion commitment.
364-day secured commitment arranged for the cash leg of the Iridium transaction.
$27.00 per share in cash on about 106 million Iridium shares.
June 30, 2026: cash $2,129.5M, current securities $172.7M, non-current securities $85.4M. It was $1,476.8M at March 31.
June 30, 2026: convertible notes net $13.1M plus $1.7M of long-term borrowings, after conversions.
The quarter changed the picture materially: $1.53 billion raised through the ATM programme took cash and securities to $2.39 billion. That sits about $473 million below the shareholder cash consideration alone, before Iridium debt repayment, transaction costs, Aireon obligations or the minimum liquidity Rocket Lab chooses to retain. The S-4 therefore models the full bridge as a financing backstop; the actual draw depends on permanent financing and cash deployment at closing.
Source: Form 8-K filed June 29, 2026; Rocket Lab Form 10-Q at June 30, 2026; Iridium Form 10-Q at June 30, 2026.
Total borrowings fell to approximately $14.8 million at June 30, 2026 before acquisition financing, while the committed bridge remains $3.60 billion. Rocket Lab now says it intends to replace the bridge through permanent debt and equity. It is seeking amendments that would allow approximately $1.775 billion of Iridium term loans to remain outstanding after closing, reducing bridge commitments at rates management describes as more attractive; lender consent is required and is not assured. The new $1.944 billion equity distribution capacity can also reduce the bridge. The permanent capital structure is therefore partly mapped, but its final cost and dilution are still open.
What has to happen before it closes
| Condition | Status at August 15, 2026 | Why it matters |
|---|---|---|
| Iridium stockholder approval, majority of outstanding shares | Pending. The preliminary proxy/prospectus has been filed, but the record date and meeting date remain blank. | Directors holding about 1.6% of shares as of June 24, 2026 signed support agreements. That is a signal, not a majority. |
| Form S-4 declared effective | Preliminary S-4 filed August 13; not yet effective | The SEC review process must advance before the definitive proxy/prospectus and vote timetable can be completed. |
| Hart-Scott-Rodino waiting period | Expired at 11:59 p.m. ET on August 12 | A material U.S. antitrust step is complete; this is not the same as completion of every regulatory condition. |
| FCC consent to transfer control of telecommunications authorisations | Applications filed August 10; consent pending | Iridium’s value rests on licensed spectrum. Filing starts the process but does not predict the approval date or result. |
| Foreign investment, satellite and telecommunications clearances elsewhere | Pending | A global network means multiple national regulators, each an independent timing risk. |
| Permanent financing | ATM/forward capacity established; debt mix and lender consents unresolved | The final balance between equity, retained Iridium debt and new permanent debt determines dilution, interest expense and flexibility. |
The outside date is June 28, 2027, extendable to September 28, 2027 and then to December 28, 2027, against a stated expectation of closing around the middle of 2027. Iridium is bound by customary no-shop restrictions and owes a termination fee of $223.62 million if it walks to a superior proposal, if its board withdraws its recommendation, or if it materially breaches the no-shop. On a $5.72 billion equity value that fee is 3.9%, within the normal range for a transaction of this size.
The strategic argument is straightforward. Spectrum is finite and internationally coordinated, and building a constellation takes years before the first dollar of recurring revenue arrives; buying an operating network with 2.6 million subscribers collapses that timeline. The vertical-integration case is more concrete still: Iridium pays third parties to launch its satellites, and a combined company would launch its own and keep the margin internally. That argument depends on Neutron, which means the acquisition and the Neutron programme are not separate stories.
How to read the preliminary S-4: it is the first quantified model of the combined company, not the final financing plan. It assumes the bridge is fully funded and outstanding through each pro forma period, excludes synergies and uses a preliminary purchase-price allocation. Actual debt, equity issuance, interest expense, goodwill and amortisation can change materially before closing.
What the August 13 preliminary S-4 changed
The filing converts several previously unknown variables into dated estimates. Using the ten-day Rocket Lab VWAP through August 7 of $69.3305, it applies a 0.3894 exchange ratio to 105,956,272 Iridium shares and estimates 41,259,372 new Rocket Lab shares. It values the stock consideration at approximately $2.861 billion, the cash consideration at $2.861 billion, Iridium equity awards at $93.8 million and payoff of existing Iridium debt at $1.775 billion, for $7.590 billion of preliminary total consideration. The approximately $8.0 billion enterprise-value headline and the $7.59 billion accounting consideration are not contradictory: they are calculated on different bases and dates.
| Preliminary S-4 item | Amount | Interpretation |
|---|---|---|
| Rocket Lab ten-day VWAP through August 7 | $69.3305 | Illustrative reference used for the pro forma filing, not the final closing reference price. |
| Exchange ratio / Rocket Lab shares issued | 0.3894 / 41.259M | Inside the collar. The final ratio changes with the contractual reference price. |
| Stock consideration | $2.861B | Fair value using the filing’s dated VWAP assumption. |
| Cash consideration | $2.861B | $27.00 for each Iridium common share used in the estimate. |
| Iridium awards plus debt payoff | $1.869B | $93.8M of awards plus $1.775B of existing debt assumed repaid in the base pro forma. |
| Total preliminary consideration | $7.590B | Accounting estimate that will be remeasured at closing. |
The first pro forma combined balance sheet
| June 30 pro forma item | Combined amount | What drives it |
|---|---|---|
| Cash and cash equivalents | $1.005B | Historical cash, transaction uses and the assumed bridge draw. |
| Bridge facility, net | $3.574B current liability | $3.600B gross proceeds less $25.66M of issuance costs. |
| Total assets / total liabilities | $11.783B / $5.244B | Preliminary combination as if closing occurred June 30, 2026. |
| Intangibles / goodwill | $4.650B / $2.501B | Large preliminary purchase-accounting values; future amortisation and impairment assumptions matter. |
| Stockholders’ equity | $6.540B | Includes the estimated stock consideration and purchase-accounting adjustments. |
The pro forma income statements show $878.708 million of revenue and a $154.677 million net loss for the first half of 2026, with basic and diluted EPS of $(0.23) on 658.944 million weighted-average shares. For full-year 2025 they show $1.473 billion of revenue and a $203.038 million net loss, or $(0.36) per share on 571.596 million weighted-average shares. These are accounting illustrations, not management guidance. The financing model assumes an approximately 8.0% effective bridge rate, creating $141.357 million of six-month and $285.669 million of annual pro forma interest amortisation. A 0.125-point rate change moves annual interest by about $4.55 million.
Aireon caveat: the June 30 pro forma does not include Iridium’s July 2 acquisition of the remaining 61% of Aireon. That transaction added a $183.4 million one-year, non-interest-bearing seller loan and consolidated Aireon term loans with $154.7 million outstanding at closing. The S-4 says the remaining balances are expected to be repaid by Rocket Lab at the Iridium closing. Those obligations therefore sit outside the displayed June 30 pro forma numbers.
The August 13 equity programme and dilution mechanics
The new prospectus supplement authorises up to $1,944,369,826 of Rocket Lab common-stock sales. It replaces the May 20 agreement and carries forward only the unsold portion of the original $3.0 billion capacity: Rocket Lab had already sold $1,055,630,173 gross. The filing explicitly says no additional amount beyond the unsold capacity is being offered. Sales can occur through ordinary ATM transactions, sales to the agents as principals, initially priced forwards or collared forwards. Commissions can be up to 2.0%.
The intended uses are transaction funding, reduction or prepayment of bridge commitments, repayment of Iridium debt and acquisition costs. If the acquisition does not close, or proceeds exceed acquisition needs, the company can use the funds for growth, acquisitions, working capital and general corporate purposes. Forward structures can delay physical share delivery and cash receipt, but they do not eliminate economic dilution. The sales agents or affiliates are also bridge lenders, which the filing identifies as a FINRA conflict of interest because they may receive 5% or more of offering proceeds.
04 Backlog, Contracts And Ceilings
Rocket Lab defines backlog as the estimated transaction prices on performance obligations for which work remains to be performed, recognised only once an enforceable agreement has been reached. That definition excludes contract ceilings, options and pipeline, which is what makes the reported number useful.
Backlog stood at $995.4 million at June 30, 2025, $1,096.0 million at September 30, $1,847.3 million at December 31 and $2,219.8 million at March 31, 2026. The sequential increase in the first quarter of 2026 was 20.2%, and the figure has more than doubled in nine months. The additions behind the record were 31 new Electron and HASTE contracts in the quarter plus five dedicated Neutron launches for a confidential customer, which is more launches sold in three months than in all of 2025.
Backlog at June 30, 2026, split by the company's own twelve-month disclosure.
- Within twelve monthsThe share the company expects to recognise inside a year. It was 36% at March 31.~$1,060.2M45%
- Beyond twelve monthsDepends on Neutron flying, on Kodiak becoming operational and on later Space Systems milestones.~$1,295.8M55%
The 45% and 55% split is the company's disclosure; the dollar amounts are that split applied to the reported total. The near-term share improved by nine points in a single quarter, which is the part of the record backlog that actually pays for the next four quarters.
Source: Rocket Lab Form 10-Q for the quarter ended June 30, 2026: remaining backlog of $2,355,949 thousand, approximately 45% expected within twelve months.
The split is more revealing than the headline. Around $799 million converts inside a year, meaningful coverage against a trailing revenue base of $679.58 million. It also said that nearly two thirds of the backlog belonged to periods that depend on Neutron flying, on Kodiak becoming operational and on Space Systems programmes reaching later milestones. At June 30 that share had fallen to 55%, with 45% now expected inside twelve months against 36% three months earlier. Backlog of this shape is a measure of demand, not a measure of near-term revenue.
Funded orders against a shared ceiling
Rocket Lab announced a large amount of government business in 2026, and not all of it is the same kind of thing. The difference is easy to lose in a headline and expensive to ignore.
Disclosed values in US$ millions. The grey bar is deliberately included: it is the item most often quoted as though it were an order.
Not an award. A ceiling shared with fourteen other vendors, running to July 29, 2032. No task order disclosed, no company press release, nothing in backlog.
August 4, 2026. Build, launch and operate. Largest single award in company history; the spacecraft fly on Neutron. An option for additional Flatellites sits inside the disclosed value.
July 27, 2026. Twelve suborbital launches with up to six more, supporting missile-defence testing. First mission no earlier than the end of 2026, primarily from Kodiak.
May 22, 2026. A Space Systems award with a number attached, which is the form of evidence that can be modelled.
May 2026. Suborbital hypersonic test launch, a government-funded line with a defined budget.
The Space Based Interceptor selection under Golden Dome, announced on May 7, 2026 with Raytheon and others, carries no disclosed value and therefore does not appear here.
Source: Company press releases on the dates shown; SpaceNews and DefenseScoop for the NITE-STAR vendor pool and ceiling (July 31, 2026).
The check to run on any government space headline is always the same. Is this a funded order with a stated value, or a position on a vehicle? Did the company itself announce it? Will it appear in backlog at the next quarter end? Applied to NITE-STAR: fifteen companies share a $981 million ceiling running to July 2032, no task order has been disclosed and Rocket Lab has published nothing about it. The other named vendors include Amentum, BAE Systems, Boeing, CACI, Firefly Aerospace, L3Harris, Lockheed Martin Space, Northrop Grumman, Pacific Crest Alliance, Parsons, Redwire, Sierra Space, Viasat and York Space Systems. Applied to the Rocket Systems Launch Program contract: a named value, a defined scope, a company press release and a first mission expected within about six months. The two were announced four days apart and carry very different evidential weight.
What the August 10 backlog figure settled: backlog at June 30 was a record $2.36 billion, up from $2,219.8 million at March 31 and up 137% year over year. The July and August awards are not in that number — the company separately stated it had already entered into more than $1 billion of new contracts across launch and space systems in Q3, which will land in the September 30 figure instead. The dollar split between Launch and Space Systems backlog was not disclosed. The $266 million launch contract of July 27 and the $397 million SB-AMTI award of August 4 both fall outside the second quarter. The June 30 backlog therefore reflects ordinary commercial bookings rather than the headline awards, and the awards themselves land in the September quarter.
Two further items in the release deserve their own line because they open a product category the company had not sold before. Rocket Lab was awarded more than $160 million across two contracts to build three geostationary satellites, including a prime contract with the Space Force’s Space Systems Command to build and operate two satellites for space domain awareness. That is the company’s first geostationary satellite production and operation work for the U.S. government, and operating a satellite is a different business from selling one. Separately it formally established Rocket Lab Germany GmbH, described as support for potential future scaling of satellite and component manufacturing in Germany and for sovereign European demand. Neither carries a disclosed margin or delivery schedule.
05 Electron And Neutron: The Cadence Business And The One That Has To Work
Electron is the operating core of Launch Services and the reason the segment margin moved. Rocket Lab describes it as the world’s most frequently launched small orbital rocket. After the successful mission of August 6, 2026, Electron stands at 92 missions overall and 13 launches in 2026.
That flight, “The Grain Goddess Provides”, lifted from Launch Complex 1 in New Zealand at 9:18 p.m. New Zealand Standard Time and deployed QPS-SAR-13, “MIKURA-I”, for Institute for Q-shu Pioneers of Space. It was the eighth QPS-SAR deployment for that customer, with 100% mission success. The commercial detail behind the flight matters more than the flight: another ten dedicated iQPS launches are already booked on Electron to complete the customer’s constellation before 2030, out of eighteen booked in total. The next Electron mission, “The Lightning God Defends”, is another iQPS flight scheduled for later in August from the same complex, with no exact date published in the August 6 release.
Two characteristics recur in the customer announcements, and they are what allow a small vehicle to command its price. The first is deployment accuracy: NASA’s June 2026 selection cited Electron’s ability to place satellites within metres of their target where the industry standard is measured in kilometres, which is what allows the PolSIR mission to put two identical CubeSats into separate 52-degree inclination orbits. The second is responsiveness: the VICTUS HAZE launch came 16 hours and 42 minutes after the notice to launch, the fastest recorded on a tactically responsive space mission, and it is the credential behind the Rocket Systems Launch Program award.
Kodiak changes the geography. The Pacific Spaceport Complex-Alaska site is being added primarily for the twelve to eighteen suborbital launches under the $266 million contract, and a fourth site adds fixed cost before it adds revenue. HASTE, the suborbital variant, is the quiet growth line behind that award and the $30 million Anduril contract: hypersonic test launch is government-funded against a defined budget line, which makes it more predictable than commercial small-satellite demand.
Neutron
Neutron is the medium-lift, partially reusable vehicle powered by eight Archimedes engines on the first stage, and it is what would let Rocket Lab launch constellation-class payloads, including its own if the Iridium transaction closes. As of the May 7, 2026 results, management described the programme as on track for a debut launch later in the year, citing first-flight hardware integration, continued Archimedes qualification and progress on the second stage and reusable fairing. In July 2026 the company reported a full-duration burn of a second-stage Archimedes engine, described as critical preparation for the first flight. The debut is planned from Launch Complex 3 at Wallops Island, Virginia.
The programme has slipped once already, from 2025 into 2026, and it could move again. What has changed is that Neutron now carries commercial commitments: five dedicated launches sold to a confidential customer in the first quarter of 2026, and the SB-AMTI Flatellites that the August 4 award requires the company to launch. Neutron is also the largest single reason research and development expense reached $80.5 million net in the first quarter of 2026 alone and $270.7 million across 2025, which is what stands between the company and positive adjusted EBITDA.
The August 10 release also introduced a third vehicle concept, GHOST, a globally deployable launch system for suborbital and orbital missions from anywhere in the world. The first location, Launch Complex 4, will be at the Pacific Spaceport Complex on Kodiak Island, Alaska, with two pads planned for high-frequency campaigns, and the operational debut is set for a suborbital launch in 2027. Read it for what it is: a 2027 item, announced by a company whose medium-lift vehicle has not yet flown, and it competes for the same engineering attention as Neutron. It matters more for the responsive-launch and hypersonic-test market, where HASTE already sells, than for the constellation economics that drive the Iridium case.
What the August 10 release said about Neutron: the wording held. The company stated that production of the Stage 1 tank “is currently aligned with the target delivery of Neutron to the launch pad in Q4 2026” and reported critical milestones across assembly, integration and testing of first-flight hardware. Note what that sentence does and does not commit to: delivery of the vehicle to the pad in Q4 2026, not a launch date. No inaugural launch date was published. The first revenue from the confidential five-launch contract and the SB-AMTI programme therefore still has no dated anchor.
06 Financials: The Second Quarter As Reported
The second quarter of 2026 was released on August 10, 2026 and beat every guided line. The table below is the reported quarter against the guidance issued on May 7 and against the prior-year quarter. The balance-sheet and prior-quarter figures that follow come from the first quarter 2026 report, for the quarter ended March 31, 2026.
| Q2 2026 metric | Reported | Guidance | Q2 2025 | Read-through |
|---|---|---|---|---|
| Revenue | $234.066M | $225–240M | $144.498M | +62% year over year, a company record |
| Product revenue | $181.3M | — | — | Space Systems remains the larger half |
| Service revenue | $52.7M | — | — | Launch and on-orbit services |
| GAAP gross margin | 36.1% | 33–35% | 32.1% | Above the band; gross profit $84.576M |
| Non-GAAP gross margin | 41.5% | 38–40% | — | Above the band |
| Adjusted EBITDA | $(8.833)M | $(20)–(26)M | $(27.584)M | The largest beat in the release |
| GAAP operating loss | $(57.514)M | — | — | R&D on Neutron is still the gap to profitability |
| GAAP net loss | $(49.258)M | — | $(66.41)M | EPS $(0.08) against $(0.13) |
| Backlog | $2.36B | — | — | Record, +137% year over year, from $2,219.8M at March 31 |
| Cash and cash equivalents | $2,129.485M | — | — | Plus $172.7M current and $85.4M non-current marketable securities |
| Operating cash flow, six months | $(134.407)M | — | — | Quarter-only figure not disclosed |
Q3 2026 guidance: revenue $250M to $265M, GAAP gross margin 29% to 31%, non-GAAP gross margin 35% to 37%, GAAP operating expenses $143M to $149M, non-GAAP operating expenses $121M to $127M, adjusted EBITDA loss $17M to $23M, net interest income $21M, basic weighted-average shares 641M including about 41M of Series A convertible participating preferred, and stock-based compensation of $18M to $20M. The revenue range would be another record; the margin range is a deliberate step down on mix, and it is the line the market reacted to on the morning of August 11, since 29% to 31% GAAP sits five to seven points below the 36.1% just reported. The dollar split of backlog between Launch and Space Systems, quarter-only operating cash flow and free cash flow were not disclosed in the release. Q2 2026 press release.
Revenue in US$ millions, as filed. The final column is the reported second quarter of 2026, a company record.
The $232.5M midpoint would be growth of 60.9% against the $144.5M of the second quarter of 2025.
Source: Rocket Lab quarterly filings. Q4 2025 is full-year revenue of $601.799M less the nine months to September 30 of $422.147M.
Gross profit divided by revenue, both as filed. Percent of revenue, scaled to the 38.2% peak.
Gross profit $35.247M on revenue of $122.569M.
Gross profit $46.388M on revenue of $144.498M.
Gross profit $57.314M on revenue of $155.080M.
Gross profit $68.232M on revenue of $179.652M, both derived from the audited full year.
Gross profit $76.493M on revenue of $200.348M. Non-GAAP margin was 43.0%.
Gross profit $84.576M on revenue of $234.066M, above the guided 33% to 35% range. Non-GAAP margin was 41.5%, above the guided 38% to 40%.
The print came in above the guided band rather than inside it, and it is the second-highest GAAP margin the company has reported, 2.1 points below the 38.2% peak of Q1 2026. Note the guidance issued for Q3 2026 is 29% to 31% GAAP and 35% to 37% non-GAAP, a deliberate step down that management attributes to mix rather than to pricing.
Source: Rocket Lab quarterly filings, the guidance issued with first quarter results on May 7, 2026 and the second quarter 2026 release of August 10, 2026.
| Metric | Q1 2026 | Q1 2025 | Reading |
|---|---|---|---|
| Revenue | $200.35M | $122.57M | Up 63.5%, a company record and the fifth consecutive quarterly increase. |
| Gross profit | $76.49M | $35.25M | GAAP margin 38.2% against 28.8%; non-GAAP 43.0% against 33.4%. |
| Research and development, net | $80.51M | $55.11M | Larger than gross profit. This is predominantly the Neutron line. |
| Net loss | $(45.02)M | $(60.62)M | Loss per share $(0.07) against $(0.12), on 605,434,642 weighted-average shares. |
| Adjusted EBITDA | $(11.75)M | $(29.96)M | The clearest measure of progress. Second quarter guidance is a loss of $20M to $26M, a deliberate step back on spending. |
| Cash used in operating activities | $(50.33)M | $(54.23)M | With $27.07M of capital expenditure, cash consumed before financing was $77.40M. |
| Cash and marketable securities | $1,476.8M | $1,098.8M at Dec 31, 2025 | Cash of $1,205.5M plus $271.3M of securities. The increase came from equity issuance, not from operations. |
| Total borrowings | $38.6M | $154.1M at Dec 31, 2025 | Convertible notes fell to a net $36.9M after 23,033,250 shares were issued on conversion. |
Two pieces of arithmetic are worth doing in the open. The first: operating cash outflow of $50.33 million plus capital expenditure of $27.07 million gives $77.40 million of cash consumed before financing in the quarter. Against $1,476.8 million of cash and securities that is roughly nineteen quarters of coverage at the first quarter rate, which is why the company does not face a funding cliff. The qualification matters as much as the number: capital expenditure rises with Neutron and with a fourth launch site, so the historical rate is a floor rather than a forecast, and it takes no account of the cash leg of the Iridium transaction.
The second: research and development of $80.51 million exceeded gross profit of $76.49 million in the quarter. A company can carry that for as long as it can fund it, and this one can. But it locates the path to profitability precisely. Adjusted EBITDA improves either when gross profit outgrows development spending or when development spending falls, and the second only happens once Neutron stops being a development programme.
07 Balance Sheet And Capital Structure
Rocket Lab does not have a debt problem. It funds itself with equity, and the share count was rising steadily before the Iridium transaction was signed.
Shares outstanding in millions. The first three columns are as filed. The fourth adds the convertible preferred. The fifth is arithmetic on the merger terms, not a company forecast.
The fourth column adds the 40.951 million Series A preferred shares to 598.180 million common shares outstanding at June 30. The fifth adds the S-4 illustration of 41.259 million merger shares, based on a 0.3894 ratio and the $69.3305 ten-day VWAP through August 7. It excludes any additional shares sold under the remaining $1.944 billion equity programme. At the collar floor the merger ratio locks at 0.4000, about 42.38 million shares; at the cap it falls to 0.2400, about 25.43 million.
Source: Rocket Lab Form 10-Q at June 30, 2026 and preliminary Form S-4 filed August 13, 2026.
Three mechanisms have been adding shares. The at-the-market programme raised approximately $1.53 billion gross during the first half of 2026 and lifted cash plus securities to $2.39 billion. The replacement agreement filed August 13 preserves another $1.944 billion of unsold capacity through ATM, principal and forward transactions; it is the remainder of the May $3.0 billion programme, not a new amount on top. Conversion of the convertible notes issued 23,033,250 shares and retired $115.87 million of debt, and that process is largely finished. Earlier collared forwards involved 7,451,200 shares for minimum expected proceeds of approximately $474.0 million and a maximum of approximately $642.0 million, maturing in April 2028.
The preferred stock is easy to miss. There were 40,951,250 Series A convertible participating preferred shares at June 30, convertible one for one. The second quarter used 629.682 million weighted-average shares and third-quarter guidance uses approximately 641 million, including roughly 41 million preferred shares. The S-4 then adds an illustrative 41.259 million merger shares to its pro forma weighted-average calculation. None of those figures includes the unknown number of shares that may be issued under the remaining equity capacity.
The dilution arithmetic, stated plainly: common shares outstanding rose from 543.575 million at December 31, 2025 to 598.180 million at June 30, a 10.0% increase before the 40.951 million preferred shares. Adding the S-4 illustration produces approximately 680.39 million common-equivalent and merger shares before any additional ATM or forward issuance. Fully selling $1.944 billion at the August 14 spot price would be roughly 24.2 million shares before commissions, but that is only sensitivity arithmetic: actual issuance depends on price, timing and transaction structure.
08 Management, Governance And Insider Activity
Sir Peter Beck is founder, President, Chief Executive Officer and Chairman. Adam Spice is Chief Financial Officer. Both signed the first quarter Form 10-Q on May 7, 2026. Concentrating the chair and the chief executive role in a founder cuts both ways: it has produced a coherent and unusually long-range strategy, and it removes a layer of independent challenge at precisely the moment the company is committing to the largest transaction in its history.
On insider activity the filings are specific. Both executives adopted Rule 10b5-1 plans on March 27, 2026: Beck with a maximum of 5,000,000 shares, expiring July 8, 2026, and Spice with 840,942 shares issuable on exercise, expiring June 30, 2027. Beck sold 3,275,779 shares between July 6 and July 8, 2026 at prices between $81.59 and $101.57, after which the trust held 1,724,221 shares alongside 491,930 held directly.
The sequencing matters and both facts are true at once. The plan was adopted three months before the merger agreement was signed and it expired on July 8, and mechanical execution across three consecutive sessions is consistent with a plan running to completion rather than a discretionary decision. It nonetheless placed a large seller into the market during the same fortnight in which the share price fell steeply. Neither reading cancels the other.
Institutional ownership stands at 51.62% and insider ownership at 1.49%, both from Finviz on August 11, 2026. A Schedule 13G was filed on Rocket Lab on July 31, 2026. Ownership percentages of this kind are market-data aggregations rather than company disclosures, and they move with each quarterly 13F cycle.
09 Market Data And Peer Comparison
The headline price and market capitalisation below are updated through the completed session of Friday, August 14, 2026. Ownership, float, short interest, volatility and the consensus target retain their stated August 10-11 Finviz observation dates. The peer table remains a same-session comparison at August 10 so the cross-company snapshot is internally consistent.
| Metric | $RKLB |
|---|---|
| Price | $80.25, up 0.19% on August 14, 2026 |
| Post-Q2 trading path | Closed $80.01 on August 11, $81.17 on August 12, $80.10 on August 13 and $80.25 on August 14 |
| Market capitalisation | ~$48.01B at the August 14 close, on 598.350M filed shares |
| Shares outstanding / float, market data | 598.18M / 589.25M |
| Shares outstanding, as filed | 598,350,482 on the Form 10-Q cover, August 5, 2026; 639,131,688 issued and 598,180,438 outstanding at June 30 |
| Short interest | 7.78% of float |
| August 14 volume | 13.86M shares; average-volume field remains the August 10 Finviz snapshot |
| Volatility, week / month | 7.57% / 7.99% |
| Performance: week / month / quarter | +13.64% / -1.23% / -31.79% |
| Performance: half year / year to date / year | +11.12% / +14.74% / +77.79% |
| Price to sales, trailing twelve months | About 62.4 times at the August 14 close, on trailing revenue of $769.15M |
| Sell-side consensus target | $116.24, Finviz aggregate, August 11, 2026 |
The share count, now that the filing has caught up: the Form 10-Q cover shows 598,350,482 shares as of August 5, 2026, and the June 30 balance sheet shows 639,131,688 issued against 598,180,438 outstanding, the difference being 40,951,250 shares held in treasury against the Series A preferred. Market data and the filing now agree to within two hundred thousand shares, where in the previous quarter they disagreed by nineteen million. The number that matters for per-share arithmetic is the weighted average: 629,681,803 in the second quarter, and a guided 641 million for the third, including roughly 41 million of Series A convertible participating preferred. Between the first quarter and the second the company raised $1.53 billion gross through its at-the-market programme, which is where most of the new shares came from.
Peer comparison, all figures at the August 10, 2026 close
| Ticker | Price | Market cap | Short float | Year to date | One year |
|---|---|---|---|---|---|
| $RKLB | $80.04 | $47.88B | 7.78% | +14.74% | +77.79% |
| $ASTS | $68.76 | $26.69B | 22.88% | -5.33% | +49.74% |
| $KTOS | $62.42 | $11.72B | 5.61% | -17.77% | -4.57% |
| $PL | $23.10 | $8.23B | 11.72% | +17.14% | +259.81% |
| $FLY | $25.76 | $4.23B | 13.86% | +15.15% | -51.96% |
| $LUNR | $15.78 | $3.42B | 27.02% | -2.77% | +55.47% |
| $RDW | $13.12 | $3.28B | 18.42% | +72.63% | +48.75% |
The comparison sets the August 10 session in context. The whole group gave ground before the results landed, so that day should not be attributed to one company announcement. $RKLB then recovered its initial August 11 pre-market drop and closed the week at $80.25, 3.1% below the August 7 close and only 0.3% above the pre-results August 10 close. The S-4, HSR and financing filings therefore added information without producing a completed-session breakout. Short interest remains the other divergence worth noting: at the dated 7.78% snapshot, $RKLB carried a materially lighter short base than $LUNR or $ASTS.
On analyst coverage the honest position is a narrow one. The $116.24 consensus target is a Finviz aggregate of third-party estimates pulled on August 11, 2026, and it predates any revision that may follow the release. Individual houses, ratings and note dates were not verified for this update, so no coverage table is presented. A consensus figure without named notes behind it is a market-data point, not research, and it is neither a company figure nor a Merlintrader forecast.
10 Retail Sentiment
The block below is a snapshot of the Stocktwits flow, with its date. These are opinions of retail traders and non-professional investors, not analyst research, and they serve as a measure of attention and of how one-sided positioning has become. They are useless for estimating what the company will earn.
The recurring themes in the flow are the August 10 print and the size of the move it might produce, the $397 million Space Force award as the anchor of the bullish case, the pairing with $ASTS which reports the same evening, and the Neutron debut. A minority strand argues the opposite case, that revenue growth is real but earnings progress is unimpressive year over year. Several posts circulate an implied move drawn from options pricing and a sell-side revenue consensus; neither figure has been verified against a primary source here and neither is treated as evidence.
What does not appear in the flow is more informative than what does. The permanent financing behind the $3.60 billion bridge, the 40.95 million preferred shares that sit outside the headline share count, and the fact that 55% of the record backlog converts beyond twelve months are all in the filings and effectively absent from the retail conversation. That gap is usually where the surprise comes from.
11 What Bulls See
The arguments below are the case its supporters make, presented as fairly as possible. They are not recommendations.
Compounding at scale, not just growth. Q2 revenue rose 62.0% year over year to a record $234.07 million. GAAP gross margin of 36.1% was above guidance and four points above Q2 2025; non-GAAP margin reached 41.5%. Revenue and gross profit grew together even as mix pulled the GAAP margin below the Q1 peak.
Operating leverage where it matters most. Launch Services gross margin rose from 20.3% to 44.3% in twelve months as mission count roughly doubled against a fixed base of three launch complexes and a factory. That is the economics of a launch business demonstrated rather than asserted.
Demand is visible and contracted. Backlog reached a record $2.36 billion at June 30, up 137% year over year, with 45% expected to convert within twelve months. The largest launch contract in company history followed in July and the $397 million SB-AMTI award followed in August; neither was inside the June 30 backlog.
Iridium adds the cash engine the model lacks. $871.7 million of 2025 revenue, $495 million of operational EBITDA, approximately 2,627,000 billable subscribers growing 6% year over year and first-half operating cash flow of $185.76 million. A recurring revenue base underneath a development programme changes the funding arithmetic if it closes.
Vertical integration with a real margin behind it. Iridium currently pays third parties to launch its satellites. A combined company launches its own and keeps that margin, which is the clearest industrial logic in the transaction.
Execution is documented, not promised. 92 Electron missions overall and 13 in 2026, eight successful QPS-SAR deployments for a repeat customer with ten more booked, ten consecutive successful launches for Synspective, and a tactically responsive mission delivered 16 hours and 42 minutes after notice.
A strong standalone balance sheet. $2.388 billion of cash and marketable securities against $14.8 million of pre-deal borrowings gives Rocket Lab substantial capacity to complete Neutron and execute contracted programmes. The qualification is the Iridium transaction: acquisition cash, debt repayment and minimum operating liquidity mean the company still needs permanent financing and may use the remaining equity programme.
12 What Bears See
The financing plan is disclosed in outline, not fixed in terms. The S-4 assumes a fully drawn $3.60 billion bridge at an approximately 8.0% effective rate, creating $285.7 million of annual pro forma interest amortisation. Management intends to replace it with permanent debt and equity, may retain Iridium’s $1.775 billion term facility if lenders consent, and has $1.944 billion of remaining equity capacity. The final interest burden and share issuance remain unknown.
The timetable is long and the remaining conditions are not routine. HSR expiry removes one U.S. antitrust step, but the S-4 is not effective, the Iridium vote is unscheduled, FCC consent is pending and foreign approvals remain. Closing is expected around mid-2027, with an outside date extendable to December 28, 2027.
Dilution is continuous and disclosed. Common shares rose from 543.575 million at year-end 2025 to 598.180 million at June 30. Add 40.951 million preferred shares, 41.259 million illustrative merger shares and whatever portion of the remaining $1.944 billion programme is actually issued.
Development spending still exceeds current operating profitability. Q2 R&D was $91.1 million against $84.6 million of gross profit. Adjusted EBITDA improved to a loss of $8.8 million, but Q3 guidance returns to a $17 million-$23 million loss as mix and spending change.
Everything industrial depends on a vehicle that has not flown. Neutron has slipped once from 2025 into 2026, now carries sold launches and SB-AMTI Flatellites, and underpins the argument that a combined company would launch its own constellation. Q2 language targets vehicle delivery to the pad in Q4 2026, not a first-launch date.
Most of the backlog is still not near-term. Roughly 55% at June 30, about $1.30 billion, converts beyond twelve months and depends on later launch and Space Systems milestones.
The valuation prices substantial execution. The August 14 market capitalisation of about $48.01 billion is roughly 62.4 times trailing revenue. The range from $150.23 in May to $58.60 in July and back to $80.25 shows that sector sentiment and financing expectations can dominate a single operating datapoint.
Red flags to keep on the list: Neutron losing its Q4 pad-delivery target or failing to produce a named launch window; an S-4 review or FCC process that stalls; lender consent to retain Iridium debt being denied; permanent financing that locks in heavy interest expense; accelerated equity issuance; backlog growth stalling; purchase-accounting assumptions moving sharply; and the Iridium spread widening.
13 Scenario Framework
The scenarios below organise what would have to happen for each path to develop. They are not forecasts, carry no probabilities or price levels, and are not recommendations.
The plan converges
Neutron reaches the pad in Q4 and receives a named flight window. The S-4 becomes effective, Iridium schedules the vote, FCC and foreign approvals progress, and permanent financing replaces the bridge at a manageable cost. Lender consent leaves part of Iridium’s $1.775 billion term loan in place, limiting expensive bridge debt, while equity issuance remains controlled. Backlog keeps converting and adjusted EBITDA resumes its narrowing path after Q3.
The deal or the vehicle breaks
A regulator blocks or materially delays the transfer of Iridium authorisations, the vote fails, Neutron suffers a major anomaly or financing markets force a large low-price equity issue or an extended bridge draw. The markers are a widening Iridium spread, delayed S-4 effectiveness, a missed Neutron milestone, lender-consent failure or permanent financing with materially worse economics than the current plan.
Between those poles sits the slower path: revenue tracks guidance, margin moves with segment mix, Neutron slips into 2027, the closing drifts toward later outside dates and equity continues funding the build. After August 13, the evidence markers are no longer whether an S-4 appears; they are whether it becomes effective, whether a vote date is set, whether FCC approval advances, how much of the $1.944 billion capacity is used and what permanent debt replaces the illustrative 8.0% bridge.
14 Merlintrader Bottom Line
Rocket Lab is now two measurable companies at once. The operating company delivered record Q2 revenue of $234.1 million, an $8.8 million adjusted EBITDA loss, $2.39 billion of liquidity and a $2.36 billion backlog. The transaction company filed a preliminary model showing $7.59 billion of estimated consideration, 41.26 million illustrative merger shares, $11.78 billion of pro forma assets and a $3.57 billion net bridge liability under the base financing assumption.
The August 13 filings reduce uncertainty without removing risk. HSR expiry is real regulatory progress; filing FCC applications is process progress, not approval. The S-4 supplies the first combined numbers, but it is preliminary and not effective. The $1.944 billion programme explains a route to bridge reduction, but it is also potential dilution. Retaining Iridium’s $1.775 billion term facility could improve the debt mix, but lender consent is not assured.
The hierarchy of evidence remains essential. Filed revenue, margin, cash, shares and backlog are facts. The $397 million, $266 million and $90 million awards are funded orders. The Iridium acquisition is signed and now supported by a preliminary proxy/prospectus, but not approved or closed. NITE-STAR is a multi-vendor ceiling, not backlog. Golden Dome is an architecture. Treating those categories as interchangeable produces the wrong model.
The shortest scorecard now has six lines: S-4 effectiveness and the Iridium vote date; FCC and foreign approvals; the amount and price of equity issued under the remaining capacity; lender consent on Iridium debt; Neutron’s Q4 pad-delivery target and first-launch window; and backlog conversion against the Q3 margin guide. The Q2 print proved the operating engine is scaling. The August 13 filings show exactly how much capital-structure execution still sits between that engine and the combined-company thesis.
Related Research On Merlintrader
- Space, Defense & AI Stock Hubs 2026: the new infrastructure race — the full index of company hubs in this sector.
- Redwire Corporation ($RDW) Stock Hub — another of the fifteen companies selected onto the NITE-STAR vendor pool.
- Firefly Aerospace ($FLY) Stock Hub — also a NITE-STAR vendor, and a direct small-launch competitor.
- AST SpaceMobile ($ASTS) Stock Hub — the other listed route into direct-to-device satellite connectivity and spectrum economics, reporting the same evening.
- Dilution, ATMs and PIPEs: how equity funding actually works — background for the capital-structure section above.
- Weekly Market Pulse — the week ahead across catalysts and earnings.
Primary Sources And Reference Links
- MDA Space — Globalstar satellites successfully launched, August 16, 2026 — first eight replenishment satellites deployed, MDA’s prime-contractor role, Montréal integration and testing, commissioning status and the nine remaining spacecraft.
- Globalstar — successful launch of all eight HIBLEO-4 replacement satellites, August 16, 2026 — Falcon 9 launch, orbital deployment, contact and initial nominal health.
- Rocket Lab — selected by MDA to design and build spacecraft for Globalstar — $143 million initial contract, spacecraft-bus scope and the 17-platform program.
- SEC EDGAR — all Rocket Lab Corporation filings (CIK 0001819994)
- Preliminary Form S-4/proxy statement-prospectus filed August 13, 2026 — merger mechanics, risk factors, preliminary consideration, purchase-price allocation and combined pro forma financial statements.
- Form 8-K filed August 13, 2026 with Iridium financials and pro forma information.
- Prospectus supplement 424B5 filed August 13, 2026 — $1.944 billion remaining equity capacity, ordinary ATM, initially priced forward and collared forward mechanics, commissions and use of proceeds.
- Form 8-K for the replacement equity distribution agreement — Deutsche Bank and Wells Fargo roles and contractual exhibits.
- Form 425 transaction progress update, August 13, 2026 — HSR expiry, FCC filings, S-4 status and the plan to seek amendments to Iridium’s $1.775 billion term facility.
- Rocket Lab Form 10-Q for the quarter ended March 31, 2026 — income statement, balance sheet, cash flow, segment note, backlog of $2,219,756 thousand with the 36% and 64% split, 578,750,990 shares outstanding at April 30, 2026, the collared forwards and the Rule 10b5-1 disclosures.
- Form 8-K filed June 29, 2026 — the Agreement and Plan of Merger dated June 28, 2026: structure, the $27.00 cash element, the collar between $67.50 and $112.50, closing conditions, the outside date, the $223.62 million termination fee, the support agreements and the $3,600.0 million bridge commitment.
- Joint Rocket Lab and Iridium press release, June 29, 2026 — the $54.00 notional, approximately $8.0 billion enterprise value, Iridium 2025 revenue of $871.7 million and operational EBITDA of $495 million, closing expected mid-2027.
- Joint investor presentation, June 29, 2026 — 66 operational satellites plus 14 on-orbit spares as of March 31, 2026, and the spectrum rationale.
- First quarter 2026 results press release, May 7, 2026 — record revenue, gross margin and backlog, 31 new Electron and HASTE contracts plus five Neutron launches, second quarter guidance, Neutron milestones, the Space Based Interceptor selection and adjusted EBITDA of negative $11.751 million.
- Second quarter 2026 results, Exhibit 99.1 to the Form 8-K of August 10, 2026, as filed with the SEC
- Rocket Lab Form 10-Q for the quarter ended June 30, 2026, filed August 10, 2026
- Form 425 of August 11, 2026 — excerpt from Sir Peter Beck’s prepared remarks on the Iridium transaction
- Rocket Lab announces second quarter 2026 financial results, August 10, 2026 — record revenue $234.1M, record backlog $2.36B, Q3 guidance and the Neutron pad-delivery wording.
- Rocket Lab announces the date of second quarter 2026 financial results, July 22, 2026 — the August 10 date and the 2:00 p.m. Pacific Time call.
- $397 million SB-AMTI award, August 4, 2026 — the Flatellite design, Neutron as the launch vehicle, mission operations from secure facilities and the option for additional spacecraft.
- Rocket Lab mission page for “The Grain Goddess Provides” / QPS-SAR-13 and the August 6, 2026 launch release — the 92nd Electron mission, 13th of 2026, eighth iQPS deployment, ten additional dedicated iQPS launches booked, and “The Lightning God Defends” scheduled for later in August.
- Record $266 million missile-defense contract with the U.S. Space Force, July 27, 2026, the iQPS multi-launch deal, July 30, 2026 and the NASA PolSIR and TSIS-2 selection, June 24, 2026.
- VICTUS HAZE mission success, July 7, 2026 and the tenth Synspective launch, June 27, 2026, source of the launch counts.
- Iridium Form 10-Q for the quarter ended June 30, 2026 — 105,960,383 shares outstanding at July 15, 2026, second quarter revenue of $225.237 million, approximately 2,627,000 billable subscribers and first-half operating cash flow of $185.762 million.
- Form 4 filed July 8, 2026 — Sir Peter Beck’s sales of 3,275,779 shares between July 6 and July 8, 2026 under the plan adopted March 27, 2026.
- SpaceNews and DefenseScoop on the NITE-STAR vehicle, its $981 million ceiling, the fifteen vendors and the July 29, 2032 end date, July 31, 2026.
- Rocket Lab investor relations · Neutron programme page · Iridium SEC filings.
- Finviz — $RKLB quote and market data · Stocktwits — $RKLB retail sentiment stream.
Rocket Lab completed-session prices are updated through the August 14, 2026 close and were checked against the daily Nasdaq historical series distributed by Yahoo Finance; the peer table remains the explicitly dated August 10 cross-company snapshot. Shares outstanding come from the Form 10-Q and S-4. Float, short interest, ownership percentages and the consensus target retain their stated Finviz observation dates. Company financial data, backlog, contract values and transaction terms come from Rocket Lab and Iridium SEC filings and company releases. Stocktwits is used only for the clearly labelled dated retail-sentiment snapshot.
Get these reports in real time
Every Merlintrader stock hub, catalyst update and market brief is published to Telegram the moment it goes live. No paywall, no spam, just the research.
Disclaimer. This content is published by Merlintrader for educational and informational purposes only. It is independent journalism and research. It does not constitute investment advice, an investment recommendation, an offer or a solicitation to buy or sell any security, and it is not a research report within the meaning of applicable United States securities regulation. Nothing here should be read as a recommendation to buy, sell or hold $RKLB or any other security.
Figures are taken from public filings with the U.S. Securities and Exchange Commission, company press releases and market-data providers, and are stated with their reference dates. Data can change without notice, and figures published before an earnings release become outdated the moment that release is issued. Merlintrader makes no representation that the information is complete or current at the time of reading. Readers should verify every figure against the primary source before acting on it.
Aerospace and defence technology companies, space-related stocks, companies with negative earnings and companies involved in pending mergers can be highly volatile and carry substantial risk. Launch vehicles fail, development programmes slip, government contracts can be reduced, delayed or cancelled, contract ceilings are not orders, and announced transactions can be delayed, renegotiated or terminated regardless of how they are described when they are signed. Companies at this stage of development can lose all of their value. Every reader is responsible for their own decisions and should consult a licensed financial adviser where appropriate.
Merlintrader may hold positions in securities mentioned. Some links on this page are affiliate or referral links, including those to Finviz and Stocktwits, which may generate a commission at no cost to the reader. Full legal information is available on the disclaimer and terms of use and privacy pages.
Earnings dates, launch windows, regulatory deadlines and clinical catalysts in one free, filterable calendar.
Open the calendar →



